LONGEVITY with Nathalie Niddam #415: Bioregulator Questions Answered: Follow Up To Dr. Bill Lawrence Episode With Nat Niddam
25 snips
Feb 24, 2026 Erin Ryan, podcast producer and health-space collaborator, co-hosts this audience Q&A. They tackle natural versus synthetic bioregulators, how short peptides survive digestion, and oral peptide quality risks. Conversation also covers organ versus system targeting, sourcing concerns, cycling and dosing strategies, and who benefits most from bioregulator use.
AI Snips
Chapters
Transcript
Episode notes
Natural Versus Synthetic Bioregulator Tradeoffs
- Natural bioregulators are animal-derived extracts (no intact protein) containing 2–4 amino acid chains plus supporting small molecules, while synthetics replicate those chains in a lab.
- Nathalie contrasts natural (slower, deeper rebuilding) with synthetic (cleaner, quicker but possibly shorter-lived) effects.
Small Bioregulators Survive And Cross The Gut Lumen
- Bioregulators survive digestion because specific proteases cleave proteins at predictable sites, releasing tiny functional peptides.
- Nathalie notes transporters move these tiny proteins across the gut into the bloodstream to reach target tissues.
Avoid Buying Peptides From Unreliable Marketplaces
- Avoid buying peptides or supplements from questionable marketplaces like Amazon because product authenticity and quality are often unreliable.
- Nathalie warns "if it's too cheap" there is usually a reason and cites examples of adulterated supplements causing harm.